Loading…
Surveillance of hand, foot, and mouth disease for a vaccine
[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be...
Saved in:
Published in: | The Lancet infectious diseases 2014-04, Vol.14 (4), p.262-263 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3 |
container_end_page | 263 |
container_issue | 4 |
container_start_page | 262 |
container_title | The Lancet infectious diseases |
container_volume | 14 |
creator | Shimizu, Hiroyuki Nakashima, Kazutoshi |
description | [...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines. |
doi_str_mv | 10.1016/S1473-3099(13)70330-X |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1511394352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147330991370330X</els_id><sourcerecordid>1511394352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</originalsourceid><addsrcrecordid>eNqFkFFLHDEQx0NRqlU_QstCXyy4NbNJbjcISpFqCwd9sIV7C9lkgrF7G012D_z25m5PBV98yjD85j-THyGfgX4HCrPTG-A1KxmV8hjYt5oyRsvFB7Kf27zkXNQ7m3pC9sinlO4ohRoo_0j2Ks4bIWW1T85uxrhC33W6N1gEV9zq3p4ULoThpMhlsQzjcFtYn1AnzP1Y6GKljfE9HpJdp7uER9v3gPy7-vn38lc5_3P9-_LHvDSi4UMJTrSWSZv3ga51xRyHWs9m1rUSGsEAGgpIGdDcrdC0M-loKwRYx03DWnZAjqfc-xgeRkyDWvpkcH0zhjEpEABMciaqjH59g96FMfb5ukxRyUWVRWVKTJSJIaWITt1Hv9TxUQFVa7tqY1et1SlgamNXLfLcl2362C7Rvkw968zAxQRg1rHyGFUyHrNZ6yOaQdng311x_ibBdL73Rnf_8RHT629UqhSdQtYZwDYJC_YEGGmbjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1509452033</pqid></control><display><type>article</type><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><source>Elsevier</source><creator>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</creator><creatorcontrib>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</creatorcontrib><description>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(13)70330-X</identifier><identifier>PMID: 24485992</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Epidemiology ; Female ; Hand, Foot and Mouth Disease - epidemiology ; Humans ; Immunization ; Infections ; Infectious Disease ; Infectious diseases ; Male ; Public health ; Vaccines</subject><ispartof>The Lancet infectious diseases, 2014-04, Vol.14 (4), p.262-263</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</citedby><cites>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24485992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, Hiroyuki</creatorcontrib><creatorcontrib>Nakashima, Kazutoshi</creatorcontrib><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</description><subject>Epidemiology</subject><subject>Female</subject><subject>Hand, Foot and Mouth Disease - epidemiology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Public health</subject><subject>Vaccines</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkFFLHDEQx0NRqlU_QstCXyy4NbNJbjcISpFqCwd9sIV7C9lkgrF7G012D_z25m5PBV98yjD85j-THyGfgX4HCrPTG-A1KxmV8hjYt5oyRsvFB7Kf27zkXNQ7m3pC9sinlO4ohRoo_0j2Ks4bIWW1T85uxrhC33W6N1gEV9zq3p4ULoThpMhlsQzjcFtYn1AnzP1Y6GKljfE9HpJdp7uER9v3gPy7-vn38lc5_3P9-_LHvDSi4UMJTrSWSZv3ga51xRyHWs9m1rUSGsEAGgpIGdDcrdC0M-loKwRYx03DWnZAjqfc-xgeRkyDWvpkcH0zhjEpEABMciaqjH59g96FMfb5ukxRyUWVRWVKTJSJIaWITt1Hv9TxUQFVa7tqY1et1SlgamNXLfLcl2362C7Rvkw968zAxQRg1rHyGFUyHrNZ6yOaQdng311x_ibBdL73Rnf_8RHT629UqhSdQtYZwDYJC_YEGGmbjQ</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Shimizu, Hiroyuki</creator><creator>Nakashima, Kazutoshi</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><author>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Epidemiology</topic><topic>Female</topic><topic>Hand, Foot and Mouth Disease - epidemiology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Public health</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, Hiroyuki</creatorcontrib><creatorcontrib>Nakashima, Kazutoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, Hiroyuki</au><au>Nakashima, Kazutoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surveillance of hand, foot, and mouth disease for a vaccine</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>14</volume><issue>4</issue><spage>262</spage><epage>263</epage><pages>262-263</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>24485992</pmid><doi>10.1016/S1473-3099(13)70330-X</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2014-04, Vol.14 (4), p.262-263 |
issn | 1473-3099 1474-4457 |
language | eng |
recordid | cdi_proquest_miscellaneous_1511394352 |
source | Elsevier |
subjects | Epidemiology Female Hand, Foot and Mouth Disease - epidemiology Humans Immunization Infections Infectious Disease Infectious diseases Male Public health Vaccines |
title | Surveillance of hand, foot, and mouth disease for a vaccine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A38%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surveillance%20of%20hand,%20foot,%20and%20mouth%20disease%20for%20a%20vaccine&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Shimizu,%20Hiroyuki&rft.date=2014-04-01&rft.volume=14&rft.issue=4&rft.spage=262&rft.epage=263&rft.pages=262-263&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(13)70330-X&rft_dat=%3Cproquest_cross%3E1511394352%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1509452033&rft_id=info:pmid/24485992&rfr_iscdi=true |